Subhan Sharief Ahmed
About Subhan Sharief Ahmed
Subhan Sharief Ahmed serves as a Senior Director at ArisGlobal in Chicago, Illinois, where he has worked since 2023. With over a decade of experience at the company and a strong background in drug safety technology, he has played a significant role in various projects and leadership positions.
Work at ArisGlobal
Subhan Sharief Ahmed has held various positions at ArisGlobal since 2012, demonstrating a progressive career trajectory within the organization. He currently serves as Senior Director, a role he has occupied since 2023. Prior to this, he held the position of Associate Director for eight years, starting in 2016. His experience also includes roles as Senior Solutions Manager and Director, showcasing his expertise in solutions management and leadership. Ahmed has been instrumental in leading teams focused on safety modernization programs and regulatory compliance initiatives.
Education and Expertise
Subhan Sharief Ahmed holds a Master of Science in Information Technology and a Master of Business Administration (MBA). His educational background includes studies in Business Administration, Management, and Operations. This academic foundation supports his extensive experience in drug safety technology and regulatory compliance, particularly in the context of safety data exchange standards.
Background
Ahmed began his career in the software industry in 2002, working as a Software Consultant at LG Soft India. He transitioned to Aris Global Software India Pvt Ltd, where he held multiple roles, including Principal Software Engineer and Team Lead. His early career included a position at LOGIPRO SOFTWARE PVT.LTD. as a Software Engineer. Over the years, he has accumulated significant experience in project management and technical architecture within the pharmaceutical technology sector.
Achievements
Subhan Sharief Ahmed played a key role in the early development of the ARISg Safety Database, contributing to advancements in drug safety technology. He co-led the implementation of Safety and E2B at the Health Canada Canada Vigilance Program, highlighting his expertise in regulatory compliance. Currently, he leads teams in the FDA FAERSII Safety modernization programs, focusing on enhancing safety reporting systems.